Transarterial, interventional radiological Treatment of hemorrhoidal disease

Transarterial, interventional radiological Treatment of hemorrhoidal disease - EMBORRHOID-MUC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016683

Enrollment

Registered

2020-03-13

Start date

2021-09-06

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K64

Interventions

Group 1: After given informed consent and respecting all inclusion and exclusion criteria, the patient is admitted to our ward. Upon thorough disinfection and placing local anesthesia, the communicati

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with symptomatic internal hemorrhoids 2nd / 3rd degree, lack of response to prior therapies (conservative basic treatment, medication, endoscopic procedures, minimally invasive procedures, contraindication to surgery and failed surgical/endoscopic treatment, negative colonoscopic correlation (during the past 24 months), no existing promising alternative endovascular/surgical therapeutic option, platelet count = 50.000 / µl, PTT < 50 s, INR < 1,5, age-adjusted normal serum creatinine or creatinine clearance = 30 ml/min / 1,73 m² for safe application of contrast media.

Exclusion criteria

Exclusion criteria: feasible surgical or endoscopic treatment, hemorrhoidal disease 1st and 4th degree, fixed prolaps, absent access via superior mesenteric artery (e.g. after hemicolectomy), after rectal resection, after endovascular aortic repair (EVAR), acute diseases like fissures, infections, abscesses etc., anatomic contraindications: stenoses, fistula, vascular occlusions, prior colorectal surgery, colorectal anomalies, allergic reactions to contrast media, severe kidney failure, pregnancy.

Design outcomes

Primary

Measure	Time frame
Evaluation of the therapeutic efficacy of the embolization of hemorroidal arteries by applying the French Bleeding Score and VAS 6 months post-interventionally.	—

Secondary

Measure	Time frame
Improvement of quality of life. Pain scale for determining the severity of the symptoms caused by the hemorrhoids	—

Countries

Germany

Contacts

Public ContactChristel Besseler

Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern

christel.besseler@med.uni-muenchen.de(089) 4400-73647

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026